![](/wp-content/uploads/2022/02/Feb-8-Cover.png)
$599
Amgen Business Review Meeting and FY ’21 Earnings; Pfizer Q4 ’21 Earnings
Two cardiometabolic-related news items have been observed: Amgen hosted a Business Review Meeting (press release; slides) and released its Q4 ’21 and FY ’21 earnings (press release); and Pfizer hosted its Q4 ’21 and FY ’21 earnings call (press release; slides). Below, FENIX provides highlights and insights for the respective new items.